Weinrebe, W. http://orcid.org/0000-0001-7425-8117
Käbe-Frisch, S.
Füsgen, I.
Karaman, M.
Johannsdottir, E.
Rupp, S.
Article History
Received: 7 February 2017
Revised: 22 January 2018
Accepted: 19 February 2018
First Online: 14 March 2018
Compliance with ethical guidelines
:
: W. Weinrebe, S. Käbe-Frisch, I. Füsgen, M. Karaman, E. Johannsdottir and S. Rupp declare that this research was partially supported by Gebro Pharma, Austria who provided desmopressin (Nocutil®) free of charge and covered the laboratory, equipment and analysis costs.
: The study was performed on the basis of ethical approval from the ethics committee of the University of Witten-Herdecke and the Landesärztekammer Rheinland-Pfalz.